Prestige Consumer Healthc... (PBH)

AI Score

Unlock

85.36

1.15 (1.37%)

At close: Mar 24, 2025, 3:59 PM

85.83

0.55%

After-hours: Mar 24, 2025, 08:00 PM EDT

1.37% (1D)

Bid	84.95
Market Cap	4.23B
Revenue (ttm)	1.12B
Net Income (ttm)	213.68M
EPS (ttm)	4.26
PE Ratio (ttm)	20.04
Forward PE	16.63
Analyst	Buy

Ask	86.72
Volume	196,393
Avg. Volume (20D)	322,967
Open	84.50
Previous Close	84.21
Day's Range	84.38 - 85.46
52-Week Range	62.35 - 90.04
Beta	0.46

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Feb 10, 2005

Employees 570

Stock Exchange NYSE

Ticker Symbol PBH

Website https://www.prestigebrands.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $98.5, which is an increase of 15.39% from the latest price.

Stock Forecasts

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on May 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+14.78%

Prestige Consumer Healthcare shares are trading hi... Unlock content with Pro Subscription

10 months ago

-7.01%

Prestige Consumer shares are trading lower after the company reported worse-than-expected Q4 financial results and issued weak guidance.

News

1 month ago · zacks.com

PBH or BSX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those...

1 month ago · zacks.com

PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%

Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.

1 month ago · seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chair...

1 month ago · zacks.com

Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago...

1 month ago · zacks.com

PBH vs. BSX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest...